Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 25.42108.7630.47-21.08-35.31

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 25.42 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08
Mar2020-35.31

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08
Negative
Mar2020 -35.31 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,848.1 Cr -1.5% -7.6% -8.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,135.0 Cr 2.6% -1.1% 38.3% Stock Analytics
DIVIS LABORATORIES ₹153,074.0 Cr -3.8% -1.9% 60.1% Stock Analytics
CIPLA ₹114,019.0 Cr -2.4% -5.2% 10.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,192.0 Cr -5.9% -9.6% 14.5% Stock Analytics
ZYDUS LIFESCIENCES ₹96,256.3 Cr -3.9% -0.3% 40.6% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-1.5%

-7.6%

-8.2%

SENSEX

-0.6%

-2.9%

6.3%


You may also like the below Video Courses